FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000993482> ?p ?o ?g. }

• W2000993482 endingPage "370" @default.
• W2000993482 startingPage "361" @default.
• W2000993482 abstract "Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy with no effective therapy for patients with unresectable disease. The aim of the current study was i) to evaluate TOP2A expression and function in human adrenocortical neoplasm and ACC cells and ii) to determine the anticancer activity of agents that target TOP2A. TOP2A mRNA and protein expression levels were evaluated in 112 adrenocortical tissue samples (21 normal adrenal cortex, 80 benign adrenocortical tumors, and 11 ACCs). In vitro siRNA knockdown of TOP2A in ACC cell lines (NCI-H295R and SW13) was used to determine its effect on cellular proliferation, cell cycle, anchorage-independent growth, and cellular invasion. We screened 14 TOP2A inhibitors for their anticancer activity in ACC cells. TOP2A mRNA and protein expression was significantly higher in ACC than in benign and normal adrenocortical tissue samples (P<0.05). Knockdown of TOP2A gene expression in ACC cell lines significantly decreased cell proliferation, anchorage-independent growth, and invasion (P<0.05). A screening assay in NCI-H295R cells showed that 11 of 14 TOP2A inhibitors had antiproliferative activity, 5 of the 14 TOP2A inhibitors had a higher antiproliferative activity than mitotane, and aclarubicin was the agent with the highest activity. Aclarubicin was validated to significantly decrease proliferation and tumor spheroid size in both NCI-H295R and SW13 ACC cell lines (P<0.05). Our results suggest that TOP2A is overexpressed in ACC, regulates cellular proliferation and invasion in ACC cells, and is an attractive target for ACC therapy. Of the TOP2A inhibitors screened, aclarubicin is a good candidate agent to test in future clinical trials for patients with locally advanced and metastatic ACC." @default.
• W2000993482 created "2016-06-24" @default.
• W2000993482 creator A5031438011 @default.
• W2000993482 creator A5051670486 @default.
• W2000993482 creator A5060590657 @default.
• W2000993482 creator A5073124516 @default.
• W2000993482 creator A5076916905 @default.
• W2000993482 creator A5081154325 @default.
• W2000993482 date "2013-03-26" @default.
• W2000993482 modified "2023-09-25" @default.
• W2000993482 title "TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma" @default.
• W2000993482 cites W1533405440 @default.
• W2000993482 cites W1903860816 @default.
• W2000993482 cites W1967352082 @default.
• W2000993482 cites W1968184070 @default.
• W2000993482 cites W1970858881 @default.
• W2000993482 cites W1976418814 @default.
• W2000993482 cites W1978408648 @default.
• W2000993482 cites W1981292619 @default.
• W2000993482 cites W1981299642 @default.
• W2000993482 cites W1989467352 @default.
• W2000993482 cites W1994325777 @default.
• W2000993482 cites W2005713943 @default.
• W2000993482 cites W2014620310 @default.
• W2000993482 cites W2026901798 @default.
• W2000993482 cites W2027344216 @default.
• W2000993482 cites W2035178765 @default.
• W2000993482 cites W2037727496 @default.
• W2000993482 cites W2040642687 @default.
• W2000993482 cites W2041051519 @default.
• W2000993482 cites W2042755939 @default.
• W2000993482 cites W2043398720 @default.
• W2000993482 cites W2048793404 @default.
• W2000993482 cites W2050209551 @default.
• W2000993482 cites W2062718503 @default.
• W2000993482 cites W2074820285 @default.
• W2000993482 cites W2089798367 @default.
• W2000993482 cites W2096051245 @default.
• W2000993482 cites W2098165008 @default.
• W2000993482 cites W2114819486 @default.
• W2000993482 cites W2121733532 @default.
• W2000993482 cites W2128879247 @default.
• W2000993482 cites W2140828821 @default.
• W2000993482 cites W2150032524 @default.
• W2000993482 cites W2164015349 @default.
• W2000993482 cites W2325777487 @default.
• W2000993482 cites W2331959261 @default.
• W2000993482 cites W2336089418 @default.
• W2000993482 cites W4239246524 @default.
• W2000993482 doi "https://doi.org/10.1530/erc-12-0403" @default.
• W2000993482 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4990817" @default.
• W2000993482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23533247" @default.
• W2000993482 hasPublicationYear "2013" @default.
• W2000993482 type Work @default.
• W2000993482 sameAs 2000993482 @default.
• W2000993482 citedByCount "60" @default.
• W2000993482 countsByYear W20009934822014 @default.
• W2000993482 countsByYear W20009934822015 @default.
• W2000993482 countsByYear W20009934822016 @default.
• W2000993482 countsByYear W20009934822017 @default.
• W2000993482 countsByYear W20009934822018 @default.
• W2000993482 countsByYear W20009934822019 @default.
• W2000993482 countsByYear W20009934822020 @default.
• W2000993482 countsByYear W20009934822021 @default.
• W2000993482 countsByYear W20009934822022 @default.
• W2000993482 countsByYear W20009934822023 @default.
• W2000993482 crossrefType "journal-article" @default.
• W2000993482 hasAuthorship W2000993482A5031438011 @default.
• W2000993482 hasAuthorship W2000993482A5051670486 @default.
• W2000993482 hasAuthorship W2000993482A5060590657 @default.
• W2000993482 hasAuthorship W2000993482A5073124516 @default.
• W2000993482 hasAuthorship W2000993482A5076916905 @default.
• W2000993482 hasAuthorship W2000993482A5081154325 @default.
• W2000993482 hasBestOaLocation W20009934821 @default.
• W2000993482 hasConcept C121608353 @default.
• W2000993482 hasConcept C126322002 @default.
• W2000993482 hasConcept C134018914 @default.
• W2000993482 hasConcept C1491633281 @default.
• W2000993482 hasConcept C173396325 @default.
• W2000993482 hasConcept C185592680 @default.
• W2000993482 hasConcept C2776735609 @default.
• W2000993482 hasConcept C2777977426 @default.
• W2000993482 hasConcept C2778041864 @default.
• W2000993482 hasConcept C2778729363 @default.
• W2000993482 hasConcept C2779707156 @default.
• W2000993482 hasConcept C2780847677 @default.
• W2000993482 hasConcept C2781399356 @default.
• W2000993482 hasConcept C29537977 @default.
• W2000993482 hasConcept C502942594 @default.
• W2000993482 hasConcept C54355233 @default.
• W2000993482 hasConcept C62112901 @default.
• W2000993482 hasConcept C71924100 @default.
• W2000993482 hasConcept C81885089 @default.
• W2000993482 hasConcept C86803240 @default.
• W2000993482 hasConceptScore W2000993482C121608353 @default.
• W2000993482 hasConceptScore W2000993482C126322002 @default.
• W2000993482 hasConceptScore W2000993482C134018914 @default.
• W2000993482 hasConceptScore W2000993482C1491633281 @default.

• next